Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial.
在 II 期随机临床试验中,Bamlanivimab 治疗期间出现了 SARS-CoV-2 逃逸突变
期刊:Nature Microbiology
影响因子:19.4
doi:10.1038/s41564-022-01254-1
Choudhary Manish C, Chew Kara W, Deo Rinki, Flynn James P, Regan James, Crain Charles R, Moser Carlee, Hughes Michael D, Ritz Justin, Ribeiro Ruy M, Ke Ruian, Dragavon Joan A, Javan Arzhang Cyrus, Nirula Ajay, Klekotka Paul, Greninger Alexander L, Fletcher Courtney V, Daar Eric S, Wohl David A, Eron Joseph J, Currier Judith S, Parikh Urvi M, Sieg Scott F, Perelson Alan S, Coombs Robert W, Smith Davey M, Li Jonathan Z